AUAUniversity · AUAUniversity PodcastEpisodes 216-220Episode 218: AUA2023: What the General Urologist Should Know about Care of Transgender Patients Episode 217: AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize OutcomesEpisode 216: AUA2023: Prostate Cancer Diagnosis Episodes 211-215Episode 215: Global Advancements in Bladder CancerEpisode
ATNM-400 demonstrated improved efficacy compared with 177Lu-PSMA-617 in treatment-resistant models as well as enhanced efficacy in combination with enzalutamide.
Data show that TAR-200 monotherapy led to high complete response rates and encouraging DFS in patients with BCG-unresponsive high-risk NMIBC.
In recent years, the use of robotic surgery in urologic oncology has rapidly increased, with growing interest in its application to functional urology.
Introduction:Although the enthusiasm for artificial intelligence (AI) to enhance surgical decision-making continues to grow, the preceding advance of risk prediction tools (RPTs) has had limited…
Jansen stresses that testosterone is not a cure-all and often requires adjunct evaluation and management of other conditions such as sleep apnea or thyroid disorders.
The most important developments in urologic education and the preparation of urologists for the effective practice of our specialty.
Single-port robotic surgery sparked interest and debate at the American Urological Association annual meeting (AUA 2025).
Ashley G. Winter, MD, reflects on the need for FDA approved testosterone formulations in women, emphasizing that urologists are well-positioned to drive change in this…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Incidental prostate cancer is typically discovered after a benign prostatic hyperplasia procedure in older men. A study compared outcomes after primary treatment.
